Zobrazeno 1 - 6
of 6
pro vyhledávání: '"T.Y. Poussaint"'
Autor:
P.M. Cogswell, J.A. Barakos, F. Barkhof, T.S. Benzinger, C.R. Jack, T.Y. Poussaint, C.A. Raji, V.K. Ramanan, C.T. Whitlow
Publikováno v:
American Journal of Neuroradiology, 43(9), E19-E35. American Society of Neuroradiology
Cogswell, P M, Barakos, J A, Barkhof, F, Benzinger, T S, Jack, C R, Poussaint, T Y, Raji, C A, Ramanan, V K & Whitlow, C T 2022, ' Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics : Detection and Reporting Recommendations for Clinical Practice ', American Journal of Neuroradiology, vol. 43, no. 9, pp. E19-E35 . https://doi.org/10.3174/ajnr.A7586
Cogswell, P M, Barakos, J A, Barkhof, F, Benzinger, T S, Jack, C R, Poussaint, T Y, Raji, C A, Ramanan, V K & Whitlow, C T 2022, ' Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics : Detection and Reporting Recommendations for Clinical Practice ', American Journal of Neuroradiology, vol. 43, no. 9, pp. E19-E35 . https://doi.org/10.3174/ajnr.A7586
SUMMARY: Monoclonal antibodies are emerging disease-modifying therapies for Alzheimer disease that require brain MR imaging for eligibility assessment as well as for monitoring for amyloid-related imaging abnormalities. Amyloid-related imaging abnorm
Publikováno v:
AJNR Am J Neuroradiol
Neuroradiologists play a key role in brain tumor diagnosis and management. Staying current with the latest classification systems and diagnostic markers is important to provide optimal patient care. Publication of the 2016 World Health Organization C
Autor:
J. Becksfort, J.T. Lucas, C.Y. Hsu, S. Vajapeyam, C. Wang, E. Simpson, J.C. Chiang, J. Armstrong, M. Soike, M. Young, B.H. Kann, Y. Li, C. Li, Z. Lu, C. Kline, S. Meuller, A. Gajjar, T.E. Merchant, S. Baker, Z. Patay, K. Wright, T.Y. Poussaint, C.L. Tinkle
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:e477-e478
Autor:
S. Vajapeyam, D. Brown, A. Ziaei, S. Wu, G. Vezina, J.S. Stern, A. Panigrahy, Z. Patay, B. Tamrazi, J.Y. Jones, S.S. Haque, D.S. Enterline, S. Cha, B.V. Jones, K.W. Yeom, A. Onar-Thomas, I.J. Dunkel, M. Fouladi, J.R. Fangusaro, T.Y. Poussaint
Publikováno v:
AJNR Am J Neuroradiol
AJNR. American journal of neuroradiology, vol 43, iss 3
AJNR. American journal of neuroradiology, vol 43, iss 3
BACKGROUND AND PURPOSE: Selumetinib is a promising MAP (mitogen-activated protein) kinase (MEK) 1/2 inhibitor treatment for pediatric low-grade gliomas. We hypothesized that MR imaging–derived ADC histogram metrics would be associated with survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee04e771a552a415a3083bd695794c23
https://europepmc.org/articles/PMC8910799/
https://europepmc.org/articles/PMC8910799/
Autor:
P.M. Cogswell, C.R. Jack, J.A. Barakos, F. Barkhof, T.S. Benzinger, C.A. Raji, T.Y. Poussaint, V.K. Ramanan, C.T. Whitlow
Publikováno v:
American Journal of Neuroradiology, 44(1). American Society of Neuroradiology
Cogswell, P M, Jack, C R, Barakos, J A, Barkhof, F, Benzinger, T S, Raji, C A, Poussaint, T Y, Ramanan, V K & Whitlow, C T 2023, ' Reply ', American Journal of Neuroradiology, vol. 44, no. 1, pp. E6 . https://doi.org/10.3174/ajnr.A7731
Cogswell, P M, Jack, C R, Barakos, J A, Barkhof, F, Benzinger, T S, Raji, C A, Poussaint, T Y, Ramanan, V K & Whitlow, C T 2023, ' Reply ', American Journal of Neuroradiology, vol. 44, no. 1, pp. E6 . https://doi.org/10.3174/ajnr.A7731
Autor:
C.A. Devine, K.X. Liu, M. Ioakeim-Ioannidou, M.S. Susko, T.Y. Poussaint, T.A.G.M. Huisman, M. Aboian, D. Brown, C. Zaslowe-Dude, A.D. Rao, L.T. Orlina, B. Rawal, S. Mueller, K.J. Marcus, S.A. Terezakis, S.E. Braunstein, D.A. Haas-Kogan
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 102:S51-S52